Wellgistics Health Provides Mid-Year 2026 Corporate Outlook

Focus is on closing DelivMeds AI transaction, driving pharmacy revenue growth and supporting PharmacyChain™, Medical Drones and Health Lives Here progressRecent capital raise provides capital into late 2026, including meeting criteria for DelivMeds AI...

Wellgistics Health Completes Reverse Split

1-for-50 reverse split of common shares outstanding now complete2,513,425 common shares now outstandingA new CUSIP was issued in connection with reverse split TAMPA, FL / ACCESS Newswire / May 26, 2026 / Wellgistics Health, Inc. (“Wellgistics”)...